Trince

Trince is a spin-off company from Ghent University with a focus on advancing cell-based science and therapeutics. The company is dedicated to facilitating the delivery of molecules into cells, both in vitro and ex vivo. Its flagship product, the LumiPore transfection platform, utilizes laser exposure and photothermal nanoparticles to convert light energy into heat, transiently permeabilizing the cellular plasma membrane. This groundbreaking technology enables the delivery of various effector molecules, such as nucleic acids or proteins, into virtually any cell type, including hard-to-transfect cells like immune cells for cell therapies. Notably, the platform not only simplifies the introduction of genetic material into cells in high-throughput but also ensures gentle delivery, thereby maximizing the therapeutic quality of the final cell product. For more information, visit www.trincebio.com.